Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License...

Related Keywords

Copenhagen ,Køavn ,Denmark ,Graham Morrell ,Paul Chaplin ,Committee For Medicinal Products Human Use ,Drug Administration ,Company Announcement ,Bavarian Nordic ,Biologics License Application ,Breakthrough Therapy ,Fast Track ,Medicinal Products ,Human Use ,Vice President Investor Relations ,Paddock Circle Advisors ,Markets ,